|
HS Code |
354136 |
| Chemicalname | 4-Amino-2,6-dimethylpyrimidine |
| Molecularformula | C6H9N3 |
| Molarmass | 123.16 g/mol |
| Casnumber | 766-12-5 |
| Appearance | White to off-white crystalline powder |
| Meltingpoint | 147-151 °C |
| Solubilityinwater | Slightly soluble |
| Smiles | CC1=NC(=NC(=C1)N)C |
| Inchi | InChI=1S/C6H9N3/c1-4-3-5(2)9-6(7)8-4/h3H,1-2H3,(H3,7,8,9) |
| Synonyms | 2,6-Dimethyl-4-aminopyrimidine |
| Storagetemperature | Store at room temperature |
| Pubchemcid | 3088762 |
As an accredited 4-Amino-2,6-Dimethylpyrimidine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging contains 25 grams of 4-Amino-2,6-Dimethylpyrimidine in a sealed amber glass bottle with a clear label. |
| Shipping | 4-Amino-2,6-Dimethylpyrimidine is shipped in tightly sealed containers, protected from light and moisture, and typically packaged according to standard chemical regulations. Transport follows local and international hazardous material guidelines, ensuring safe handling and labeling to prevent leaks or contamination during transit. Storage and shipment are at ambient temperature unless otherwise specified. |
| Storage | 4-Amino-2,6-Dimethylpyrimidine should be stored in a tightly sealed container, in a cool, dry, and well-ventilated area away from incompatible substances such as strong oxidizers. Protect from moisture and direct sunlight. Label clearly and keep away from sources of ignition. Store at room temperature, and follow all relevant safety and regulatory guidelines for handling chemicals. |
Applications of 4-Amino-2,6-Dimethylpyrimidine in Industrial Manufacturing4-Amino-2,6-Dimethylpyrimidine supports critical synthesis pathways across fine chemical and pharmaceutical manufacturing. Our facility ensures consistent analytical purity and reliable supply for specialized downstream integrations. Below, we outline leading applications observed in actual user industries, detailing compliance systems, recommended process approaches, and the final end products where this chemical intermediate plays a decisive role. 1. Active Pharmaceutical Ingredient (API) Intermediates for Antiviral DrugsPharmaceutical manufacturers frequently source 4-Amino-2,6-Dimethylpyrimidine as a key intermediate for the synthesis of pyrimidine-based antiviral agents, particularly for nucleoside analogs. Formulators require tightly controlled molar ratios and validated impurity profiles. Integration occurs at early-stage heterocycle formation or as a coupling partner in multi-step syntheses. Process setup involves high-purity raw material charging to ensure consistent yield and simplified downstream purification. Application is closely regulated due to the APIs’ direct patient use. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Crop Protection Active Ingredient SynthesisIn agrochemical production, leading technical-grade product manufacturers utilize 4-Amino-2,6-Dimethylpyrimidine as a core intermediate for specific pyrimidine-based herbicides and fungicides. Integration focuses on key condensation reactions and ring substitutions. Material traceability and low moisture levels are enforced to maintain batch-to-batch uniformity. Downstream, precision of raw material intake and reaction time is closely monitored to support consistent conversion rates. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Veterinary Pharmaceutical Compound Manufacturing4-Amino-2,6-Dimethylpyrimidine features in the synthesis of veterinary drugs, specifically those involving pyrimidine nuclei such as coccidiostats or antiparasitic agents. Animal health manufacturers require manufacture under quality systems enforcing both batch uniformity and documentation required for regulatory submission. Typical use involves nucleophilic aromatic substitution or integration during late-stage modification. Downstream, robust quality assurance is required to meet regional veterinary product registrations. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Pharmaceutical Pyrimidine Derivative Synthesis for R&DResearch institutions and contract development organizations (CDMOs) rely on the consistent properties of 4-Amino-2,6-Dimethylpyrimidine to develop new pyrimidine-based drug scaffolds. Our plant produces lab and pilot scale lots meeting stringent analytical criteria, ensuring researchers can reproduce synthetic routes. Typically, usage adapts to experimental protocol objectives, with process development scientists adjusting equivalents and solvents during pre-clinical candidate selection. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Fine Chemical Intermediate for Dye and Pigment ProductionBases for certain functional dye classes are prepared using 4-Amino-2,6-Dimethylpyrimidine as a reactive nucleophile, particularly in the synthesis of heteroaromatic dye intermediates. Industrial users require strict color index control and reproduction. Material enters during the formation of the dye’s chromophore core, demanding consistent reactivity to maintain batch reproducibility. Finished pigments depend on the precise structure imparted by the pyrimidine nucleus. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 4-Amino-2,6-Dimethylpyrimidine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
For decades, we have specialized in the synthesis and purification of heterocyclic intermediates, and 4-Amino-2,6-Dimethylpyrimidine stands out as a benchmark for both purity and stability in our catalogue. This compound, often recognized by its CAS number 56-05-3, has become an essential building block for clients working in pharmaceuticals, crop sciences, pigments, and high-performance materials. Our direct experience in high-volume and high-purity manufacturing has shaped every decision we make, from raw material selection through to final packaging.
The core principle guiding our manufacturing line is dependability. 4-Amino-2,6-Dimethylpyrimidine’s structure – a six-membered ring with amino and methyl functional groups – delivers a unique balance between reactivity and resistance to oxidative damage during synthetic reactions. After dozens of optimizations over the years, our best-performing batches reach a purity of 99% or higher. Such a high specification is rarely the result of one-step synthesis. Each lot undergoes rigorous monitoring: we rely on advanced HPLC, NMR spectroscopy, and elemental analysis for every batch, and we reject any lot that falls below the established performance benchmarks.
Researchers and industrial partners are always in pursuit of materials that remove bottlenecks in complex syntheses. 4-Amino-2,6-Dimethylpyrimidine serves as a reliable coupling partner in the construction of advanced pharmaceuticals, particularly those built on dihydropyrimidine scaffolds, sulfonamide derivatives, and kinase inhibitors. We’ve supplied this compound for projects where even minor impurities could derail expensive multistep syntheses. Its use doesn’t stop there—the agricultural sector seeks it for innovative crop protection agents, while specialty chemical manufacturers rely on its resilience under high-temperature conditions.
Through years of feedback from our clients, we’ve learned that minor differences in aromatic substitution patterns lead to significant changes in solubility, shelf stability, color, and downstream reaction yields. Even seemingly subtle variations in methyl group positioning, for instance, can mean the difference between a viable intermediate and a dead-end byproduct. We have a close partnership with quality-focused pharmaceutical groups who can trace scale-up setbacks to small variations in raw materials, so we engineered our processes accordingly. Consistency and reliability are not marketing claims for us—these are survival necessities in a business that faces regulatory audit and market scrutiny.
In pyrimidine chemistry, cross-contamination and isomeric impurities often create obstacles for innovation. By investing in ultra-clean facilities and strictly controlled crystallization protocols, we control most side reactions that can introduce 2-methyl, 4-methyl, or diaminopyrimidine contaminants. This level of effort may seem extreme, but batch rejections in medicinal research programs prove far costlier than upfront investment in quality controls. Our analytical chemists have seen how the minor presence of related substances can not only impair synthesis but generate misleading toxicology data, which cannot be tolerated by companies that operate under GMP or ISO accreditation.
It’s one thing to achieve claimed purity on paper; it’s another to demonstrate it repeatedly under actual storage and transport conditions. Our product holds form and color after months in darkened, sealed drums, with each lot accompanied by a detailed batch release certificate. Stability testing is not an afterthought—we include accelerated degradation tests in all stability protocols, updating shelf-life projections whenever we make improvements in processing or packaging.
Clients sometimes ask if cheaper substitutes could perform equally well in their synthetic routes. Our answer draws on decades of kinetic screening and end-use trials: the specific substitution at the 2,6-methyl positions, combined with the 4-amino group, gives this molecule a balance of nucleophilicity and steric profile not found in simple pyrimidines or other methylated pyrimidine analogues. The result is improved selectivity during alkylation, arylation, and cyclization steps. Where minor impurities from inadequately separated 2,4- or 4,6-dimethylpyrimidines have stalled downstream chemistry, our clients have found progress only after switching to a rigorously controlled form of the 2,6-dimethyl variant.
The highly reproducible melting point, consistent color, low hygroscopicity, and reduced dust generation during transfer make our material easier to handle on a factory floor compared to more variable alternatives. Many companies working with similar pyrimidines contend with variable residual solvent levels due to less effective drying or purification protocols. After tightening our process parameters and implementing in-line controls, we have reached consistently low solvent residues—well below international health and safety limits.
Our direct relationships with synthetic chemists and process engineers have shaped both our product line and our philosophy. Large buyers visit our site, walk through production halls, and participate in on-site audits before making substantial commitments. We believe every customer should have this level of confidence in their supply chain, especially where the cost of project delays reaches millions of dollars per week. The feedback we gain from these visits often leads to process refinements or new packaging configurations—some clients need anti-static liners, others favor moisture-barrier drums.
Accurate documentation comes from workers who know every corner of the plant: from solvent tanks to filtration units, to the final step of double-bagging and labeling. Regular third-party inspections complement our internal training programs, keeping quality at the level that the industry now expects as a minimum.
Experience shows that regulatory compliance cannot be an afterthought. We design every batch record, cleaning cycle, and handling protocol for full transparency—operators log every intervention directly into electronic records, making traceability straightforward. As countries strengthen rules around pharmaceutical starting materials and agricultural chemicals, traceability has grown from a nice-to-have to a non-negotiable requirement. We provide full documentation packages, including material origin, processing history, and contaminant analysis, which reduces audit friction for our partners.
We adapt actively to changes in allowable impurity thresholds, toxicological classifications, and container labeling standards. When a regulatory body releases a new safety guideline, we roll that into our SOPs after internal review. Waiting for clients to flag regulatory gaps is never part of our approach. We communicate upcoming changes in specifications and labeling to key buyers, and we work with our logistics partners to minimize customs or regulatory delays that could disrupt time-sensitive projects.
Stability begins at the plant, but packaging preserves it through the last mile. From the time the compound leaves our facility, it is shielded from light, atmospheric moisture, and temperature extremes. For large scale deliveries, we use coated steel drums with tamper-proof seals and secondary containment. Smaller laboratory batches are packed in amber glass bottles, using an outer layer to guard against shocks. Over the years, we have streamlined this process with anti-static measures, desiccant packs, and resealable closures, all based on real incidents experienced by clients in their own plants—ruptured bags, irregular fill weights, and accidental spillage.
We maintain live tracking on all shipments so buyers always know product location and estimated arrival. Experience tells us that small delays at customs or dockside handling can cascade into lost lab days, so we’ve prioritized partnerships with forwarders who specialize in chemical handling, not generalized freight.
Problems don’t end with batch production. Often, clients approach us with requests to tweak specifications or explore higher-purity options for special projects. We see ourselves not as simple commodity suppliers, but as partners in process development. For example, we have worked with researchers scaling from 100-gram pilot runs to multi-ton annual volumes, carefully documenting and controlling every deviation in the process. Where classical batch crystallization produced unacceptable isomer ratios, we introduced continuous-flow technology to minimize side-product formation, ultimately delivering purer product and reducing downstream purification steps.
Our scientists have run joint experiments with university partners to improve coupling yields in nucleoside analog synthesis, sharing both successes and setbacks. By openly sharing lessons learned on incremental improvements—dryer bed optimization, finer control over reaction temperature, or solvent recycle methods—we not only push our own boundaries, but help our clients leap ahead in their fields.
A chemical is only as sustainable as the method used to produce it. Years of environmental audits have shown us how small changes in waste handling, solvent recovery, and emissions monitoring make a measurable difference. Our production environment uses closed-loop solvent systems and advanced ventilation to minimize fugitive emissions. Waste minimization is not only an environmental imperative, but also a cost-saving measure—our controlled synthesis generates less off-spec product, less solvent waste, and less hazardous effluent than less-refined heritage methods.
Worker safety lies at the heart of long-term manufacturing. Through frequent risk assessments and real-world training, our staff knows how to manage hazards, from flammable solvents to amine fumes, without shortcuts. Accidents became less frequent once we invested in state-of-the-art ventilation and enforced rigorous PPE policies, and this commitment has also paid off in fewer unplanned shutdowns and improved job satisfaction.
We don’t see our process as static. Benchmarking against the best manufacturers worldwide keeps us competitive and honest. Every year, client feedback and regulatory requirements push us to revisit established SOPs and analytical protocols. Our R&D group regularly assesses emerging purification media and inline monitoring techniques, aiming to push purity limits up and production costs down. For compounds as central as 4-Amino-2,6-Dimethylpyrimidine, this ongoing drive means improved shelf life, lower impurity burdens, and more consistent physical form.
As the pharmaceutical and agrochemical industries pursue increasingly complex targets, the need for ever-more reliable intermediates will only grow. We recognize the responsibility that comes with being a trusted source of these fundamental building blocks. Our decades of work in pyrimidine chemistry have taught us respect for both the science and the end user. Every improvement in process control, analytical rigor, and environmental stewardship finds its way into the product leaving our doors.
The journey from raw materials to a reliable bottle of 4-Amino-2,6-Dimethylpyrimidine reflects more than synthetic skill; it marks an ongoing commitment to every partner’s success. By openly addressing batch variability, handling realities, and the sometimes-unforgiving pace of regulated industries, we aim for more than transactional relationships. Our investment in quality, transparency, and problem-solving ensures that every gram shipped is ready for high-stakes research, full-scale production, or game-changing innovation. In an industry where quality compounds power future breakthroughs, we remain as focused on continuous improvement as we were on day one.